Fundraising Fox
Hememics
2 known investors
Find your way into Hememics
Sign up to see every warm intro you have to Hememics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hememics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hememics develops FAST (Functionalized Analyte Screening Technology), an immunoassay-based screening platform that lets researchers use their own antibodies and antigens to screen antibody mini-panels in under an hour. Positioned as a faster, lower-cost alternative to ELISA, it delivers digital end-point results using a 96-well plate and a compatible reader.
Founders & leadership
Investors · 2
How we know: Maryland TEDCO's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $185.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Hememics do?
- Hememics develops FAST (Functionalized Analyte Screening Technology), an immunoassay-based screening platform that lets researchers use their own antibodies and antigens to screen antibody mini-panels in under an hour. Positioned as a faster, lower-cost alternative to ELISA, it delivers digital end-point results using a 96-well plate and a compatible reader.
- Who founded Hememics?
- Hememics was founded by John L. Warden, Jr., David Ho.
- Who are Hememics's investors?
- Hememics's investors include Maryland TEDCO, TEDCO.